Hsu S I, Lothstein L, Horwitz S B
Department of Molecular Pharmacology, Albert Einstein College of Medicine, Bronx, New York 10461.
J Biol Chem. 1989 Jul 15;264(20):12053-62.
A hallmark of the multidrug-resistant phenotype is the overproduction of a family of 130-180-kDa integral membrane phosphoglycoproteins collectively called P-glycoprotein. Gene-specific hybridization probes were derived from three classes of mouse P-glycoprotein cDNAs. These probes revealed the differential amplification and/or transcriptional activation of three distinct but closely related mdr genes (mdr1a, mdr1b, and mdr2) in independently selected multidrug-resistant J774.2 mouse cell lines. Overexpression of mdr1a and mdr1b was found to correlate, in general, with the differential overproduction of either a 120- or 125-kDa P-glycoprotein precursor, respectively. This same correlation was observed in a single cell line during the course of stepwise selection for resistance to vinblastine in which a switch in gene expression from mdr1b to mdr1a resulted in a switch from the 125- to 120-kDa P-glycoprotein precursor. These findings suggest that differential overexpression of distinct mdr genes which encode unique P-glycoprotein isoforms is a possible mechanism for generating diversity in the multidrug-resistant phenotype.
多药耐药表型的一个标志是一族分子量为130 - 180 kDa的整合膜磷酸糖蛋白过量产生,这些蛋白统称为P - 糖蛋白。基因特异性杂交探针源自三类小鼠P - 糖蛋白cDNA。这些探针揭示了在独立选择的多药耐药J774.2小鼠细胞系中,三个不同但密切相关的mdr基因(mdr1a、mdr1b和mdr2)的差异扩增和/或转录激活。一般发现,mdr1a和mdr1b的过表达分别与120 kDa或125 kDa P - 糖蛋白前体的差异过量产生相关。在对长春碱耐药的逐步选择过程中,在一个单细胞系中也观察到了同样的相关性,其中基因表达从mdr1b转换为mdr1a导致了从125 kDa P - 糖蛋白前体到120 kDa P - 糖蛋白前体的转换。这些发现表明,编码独特P - 糖蛋白异构体的不同mdr基因的差异过表达是在多药耐药表型中产生多样性的一种可能机制。